Latest Impact Factor: 7.786
The Official Journal of: American Thyroid Association®
FREE ACCESS through May 8, 2020.
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies
Tiffany Yeh, Michele Yeung, Eric J. Sherman, R. Michael Tuttle, and Mona M. Sabra
Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression
Nina-Maria Wilpert, Martin Krueger, Robert Opitz, David Sebinger, Sarah Paisdzior, Bianca Mages, Angela Schulz, Joachim Spranger, Eva K. Wirth, Harald Stachelscheid, Philipp Mergenthaler, Peter Vajkoczy, Heiko Krude, Peter Kühnen, Ingo Bechmann, and Heike Biebermann
Patient Report of Recurrent and Persistent Thyroid Cancer
Maria Papaleontiou, Josh M. Evron, Nazanene H. Esfandiari, David Reyes-Gastelum, Kevin C. Ward, Ann S. Hamilton, Francis Worden, and Megan R. Haymart
Patient Preferences Around Extent of Surgery in Low-Risk Thyroid Cancer: A Discrete Choice Experiment
Sara Ahmadi, Juan Marcos Gonzalez, Maya Talbott, Shelby D. Reed, Jui-Chen Yang, Randall P. Scheri, Michael Stang, Sanziana Roman, and Julie Ann Sosa
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.